65 related articles for article (PubMed ID: 6440503)
1. [Hemodynamic effects of a new positive inotropic agent (AR-L 115 BS) in ischemic and nonischemic myocardiopathies].
Colle JP; Ohayon J; Ledain L; Besse P
Arch Mal Coeur Vaiss; 1984 Dec; 77(13):1532-9. PubMed ID: 6440503
[TBL] [Abstract][Full Text] [Related]
2. The acute effect of a new positive inotropic agent (AR-L 115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure.
Hauf GF; Bubenheimer P; Roskamm H
Arzneimittelforschung; 1981; 31(1a):253-6. PubMed ID: 7195235
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of single-dose administration of AR-L 115 BS in patients with coronary artery disease.
Weikl A; Kohlschütter S; Durst OE; Lang E
Arzneimittelforschung; 1981; 31(1a):244-7. PubMed ID: 7195232
[TBL] [Abstract][Full Text] [Related]
4. The hemodynamic effect of AR-L 115 BS, a new positive-inotropic agent, in patients with left ventricular failure.
Wollschläger H; Drexler H; Löllgen H; Just H
Arzneimittelforschung; 1981; 31(1a):248-50. PubMed ID: 7195233
[TBL] [Abstract][Full Text] [Related]
5. Study of the acute effect of AR-L 115 BS, a new positive-inotropic agent in patients with exercise-induced heart failure.
Drexler H; Wollschläger H; Löllgen H; Just H
Arzneimittelforschung; 1981; 31(1a):259-62. PubMed ID: 7195237
[TBL] [Abstract][Full Text] [Related]
6. Effects of AR-L 115 BS on hemodynamics and contractility of the heart in cardiac patients.
Stauch M; Nechwatal W
Arzneimittelforschung; 1981; 31(1a):267-71. PubMed ID: 7195239
[TBL] [Abstract][Full Text] [Related]
7. Acute clinical benefits of a new inotropic agent AR-L 115 BS after i.v. and oral administration.
el Allaf D; D'Orio V; Cremers S; Carlier J
G Ital Cardiol; 1984 Oct; 14(10):830-4. PubMed ID: 6519393
[TBL] [Abstract][Full Text] [Related]
8. A new orally active positive inotropic substance: AR-L 115 BS.
Ruffmann KD; Mehmel HC; Kübler W
Arzneimittelforschung; 1981; 31(1a):271-3. PubMed ID: 7195240
[TBL] [Abstract][Full Text] [Related]
9. A new non-glycoside, non-adrenergic cardiotonic agent AR-L 115 BS. Hemodynamic proof of its efficacy after both i.v. and oral administration.
Thormann J; Kramer W; Schlepper M
Arzneimittelforschung; 1981; 31(1a):273-8. PubMed ID: 7195241
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of a new antiarrhythmic agent: cibenzoline.
Rigaud M; Jouret G; Canal M; Bardet J; Flouvat B; Bourdarias JP
J Pharmacol; 1985; 16(3):247-57. PubMed ID: 4068726
[TBL] [Abstract][Full Text] [Related]
11. [Hemodynamics and clinical data in chronic coronary disease with severe left ventricular systolic dysfunction].
Marinato PG; Dametto E; Maragno I; Razzolini R; Chinellato P; Santostasi G; Dalla Volta S
Cardiologia; 1996 Apr; 41(4):349-59. PubMed ID: 8674104
[TBL] [Abstract][Full Text] [Related]
12. [Sulmazole: a new positive inotropic agent].
Renard M; Jacobs P; Melot C; Dresse A; Bernard R
Ann Cardiol Angeiol (Paris); 1984; 33(4):219-22. PubMed ID: 6465815
[TBL] [Abstract][Full Text] [Related]
13. Onset and magnitude of cardiovascular response to dobutamine and AR-L 115 BS, a new positive inotropic agent with additional vasodilating activity, in normal subjects.
Benedikter L; Mey T
Arzneimittelforschung; 1981; 31(1a):239-42. PubMed ID: 7195230
[TBL] [Abstract][Full Text] [Related]
14. [Effect of sulmazol on left ventricular function in congestive cardiomyopathy].
Maurer E; Klein W; Brandt D
Arzneimittelforschung; 1983; 33(5):760-3. PubMed ID: 6683555
[TBL] [Abstract][Full Text] [Related]
15. Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent.
Kitzen JM; Lynch JJ; Driscoll EM; Lucchesi BR
J Pharmacol Exp Ther; 1988 Mar; 244(3):929-39. PubMed ID: 3252039
[TBL] [Abstract][Full Text] [Related]
16. [Hemodynamic effects of ARL 115 in left ventricular insufficiency].
Drobinski G; Komajda M; Lechat P
Ann Cardiol Angeiol (Paris); 1984 Nov; 33(7):475-9. PubMed ID: 6508198
[TBL] [Abstract][Full Text] [Related]
17. Influence on hemodynamic parameters after parenteral administration of AR-L 115 BS in patients with acute myocardial infarction.
Nebel W; Sabin G; Surawitzki G
Arzneimittelforschung; 1981; 31(1a):251-3. PubMed ID: 7195234
[TBL] [Abstract][Full Text] [Related]
18. Interaction of AR-L 115 BS with isoprenaline on hemodynamic parameters in the isolated guinea pig heart.
Schrader J
Arzneimittelforschung; 1981; 31(1a):183-5. PubMed ID: 7195216
[TBL] [Abstract][Full Text] [Related]
19. Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS.
Diederen W; Kadatz R
Arzneimittelforschung; 1981; 31(1a):141-6. PubMed ID: 7195207
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic activity of different doses of sulmazole by infusion.
Mendiola-García A; Fernández-Fernández JL; Tello-Arias A; Camacho-Rivera B
Arzneimittelforschung; 1983; 33(11):1594-8. PubMed ID: 6686455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
